MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: Oxaliplatin Phase 1 (Zyklen 1-6, dann abgebrochen)

Raw json | Download

{
  "resourceType" : "MedicationStatement",
  "id" : "mii-exa-onko-modification-oxaliplatin-phase1",
  "meta" : {
    "profile" : [
      🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie-medikation"
    ]
  },
  "language" : "de",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement mii-exa-onko-modification-oxaliplatin-phase1</b></p><a name=\"de-mii-exa-onko-modification-oxaliplatin-phase1\"> </a><a name=\"de-hcmii-exa-onko-modification-oxaliplatin-phase1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-onko-systemische-therapie-medikation.html\">MII PR Onkologie Systemische Therapie Medikation</a></p></div><p><b>basedOn</b>: <a href=\"CarePlan-mii-exa-onko-tumorkonferenz-folfox-modification.html\">CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05</a></p><p><b>partOf</b>: <a href=\"Procedure-mii-exa-onko-folfox-phase1.html\">Procedure Nicht komplexe Chemotherapie</a></p><p><b>status</b>: Stopped</p><p><b>statusReason</b>: <span title=\"Codes:{http://snomed.info/sct 281647001}\">Grade 3 peripheral neuropathy (CTCAE) - cumulative neurotoxicity from oxaliplatin</span></p><p><b>medication</b>: <span title=\"Codes:{http://fhir.de/CodeSystem/bfarm/atc L01XA03}\">Oxaliplatin</span></p><p><b>subject</b>: <a href=\"Patient-example-modification.html\">Martin Beispiel  Male, DoB: 1958-11-03</a></p><p><b>effective</b>: 2024-03-15 --&gt; 2024-06-10</p><p><b>note</b>: </p><blockquote><div><p>FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.</p>\n</div></blockquote></div>"
  },
  "basedOn" : [
    {
      🔗 "reference" : "CarePlan/mii-exa-onko-tumorkonferenz-folfox-modification"
    }
  ],
  "partOf" : [
    {
      🔗 "reference" : "Procedure/mii-exa-onko-folfox-phase1"
    }
  ],
  "status" : "stopped",
  "statusReason" : [
    {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "281647001",
          "display" : "Adverse reaction (disorder)"
        }
      ],
      "text" : "Grade 3 peripheral neuropathy (CTCAE) - cumulative neurotoxicity from oxaliplatin"
    }
  ],
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://fhir.de/CodeSystem/bfarm/atc",
        "code" : "L01XA03",
        "display" : "Oxaliplatin"
      }
    ],
    "text" : "Oxaliplatin"
  },
  "subject" : {
    🔗 "reference" : "Patient/example-modification"
  },
  "effectivePeriod" : {
    "start" : "2024-03-15",
    "end" : "2024-06-10"
  },
  "note" : [
    {
      "text" : "FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities."
    }
  ]
}